3 results match your criteria: "CHU Lille and Lille-2 University[Affiliation]"
Am J Gastroenterol
October 2013
Gastroenterology Unit, Lille University Nord de France, CHU Lille and Lille-2 University, Lille, France.
Objectives: Although the incidence of pediatric inflammatory bowel disease (IBD) continues to rise in Northern France, the risks of death and cancer in this population have not been characterized.
Methods: All patients <17 years, recorded in EPIMAD registry, and diagnosed between 1988 and 2004 with Crohn's disease (CD) or ulcerative colitis (UC) were included. The observed incidences of death and cancer were compared with those expected in the regional general population obtained by French Statistical Institute (INSEE) and the cancer Registry from Lille.
Dig Liver Dis
February 2013
Univ Lille Nord de France, CHU Lille and Lille-2 University, Epidemiology Unit, EPIMAD Registry, EA 2694, France.
Most data regarding the natural history of inflammatory bowel diseases and their therapeutic management are from tertiary referral-centres. However, the patients followed in these centres represent a selected sample and extrapolation of these data to the general population is disputable. The EPIMAD Registry covers a large area of Northern France with almost 6 million inhabitants representing 9.
View Article and Find Full Text PDFInflamm Bowel Dis
January 2013
Univ Lille Nord de France, CHU Lille and Lille-2 University, Gastroenterology Unit, France.
Background: To describe long-term postoperative evolution of pediatric-onset Crohn's disease (CD) and identify predictors of outcome we studied a population-based cohort (1988-2004) of 404 patients (0-17 years), of which 130 underwent surgery.
Methods: Risks for a second resection and first need for immunosuppressors (IS) and/or biologics were estimated by survival analysis and Cox models used to determine predictors of outcome. Impact of time of first surgery on nutritional catch-up was studied using regression.